First malaria drug for babies is approved in ‘major public health milestone’

The Guardian · 🇬🇧 public United Kingdom · May 02, 2026 · 502 words · By Kat Lay

Public Health Innovation Global Health Inequality Pharmaceutical Corporate Social Responsibility

headphones Listen to the eFinder podcast briefing

Generate a natural audio summary of this story

Daily briefing

What to know about Public Health Innovation

The first malaria treatment for babies has been approved by the World Health Organization, opening the door to widespread use around the globe.

Claims checked 11

Techniques found 2

Topics 3

Coverage spectrum

Coverage gap: Low Right coverage

Left14%

Center86%

Right0%

7 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

The first malaria treatment for babies has been approved by the World Health Organization, opening the door to widespread use around the globe.

Why it matters

In parts of Africa, up to 18% of children under six months will be infected with malaria, but there has historically been no safe treatment for the smallest of them.

Common ground

There were 610,000 deaths from malaria in 2024, about three quarters of which were under-fives in Africa.

Perspective signals

The tension in the story is sharpened by Loaded Language, Appeal to Pity: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

Follow-up questions

What new context would change how readers understand this Public Health Innovation story?
What evidence would most clearly confirm or weaken the claim that In parts of Africa, up to 18% of children under six months will be infected with malaria?
How does this story connect Public Health Innovation with Global Health Inequality over the next few days?

open_in_new Read the original article: https://www.theguardian.com/global-development/2026/may/02/new-drug-coartem-baby…

psychologyPropaganda Techniques Detected

eFinder identified 2 propaganda techniques in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning

Loaded Language 80% confidence

Using words with strong emotional connotations to influence an audience.

Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.

Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

warning

Appeal to Pity 70% confidence

Evoking sympathy to win support rather than using logical arguments.

Why it matters: Recognizing appeal to pity helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 11 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 6

info Single Source 2

schedule Pending 1

verified Verified By Reference 1

help Insufficient Evidence 1

info

Claim 1: “In parts of Africa, up to 18% of children under six months will be infected with malaria”

SINGLE SOURCE

The provided evidence for this claim consists of irrelevant search results regarding Google Authenticator and Gmail accounts; no medical or statistical data regarding malaria infection rates in infants was provided.

travel_explore

web search NEUTRAL — The Google Authenticator app can generate one-time verification codes for sites and apps that support Authenticator app 2-Step Verification. If you set up 2-Step Verification, you can use the Google
https://support.google.com/accounts/answer/1066447?hl=en&co=…

travel_explore

web search NEUTRAL — If you've set up 2-Step Verification but can't find the option to add an app password, it might be because: Your Google Account has 2-Step Verification set up only for security keys.
https://support.google.com/accounts/answer/185833?hl=en

travel_explore

web search NEUTRAL — Important: Before you set up a new Gmail account, make sure to sign out of your current Gmail account. Learn how to sign out of Gmail. From your device, go to the Google Account sign in page. Click Cr…
https://support.google.com/mail/answer/56256?hl=en

schedule

Claim 2: “The Gates Foundation... is also among the donors to the Medicines for Malaria Venture”

PENDING

This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.

check_circle

Claim 3: “Coartem Baby, which can be used to treat infants as small as 2kg (4.4lb)”

CORROBORATED

Multiple sources, including Drugs.com and Swissmedic reports, confirm Coartem Baby is approved for infants weighing 2 to 5 kg (4.4 to 11 lbs).

travel_explore

web search NEUTRAL — Coartem Baby is a formulation approved internationally for infants weighing 4.4 to 11 pounds (2 to 5 kg). It can be mixed with breast milk. It easily dissolves and has a sweet cherry flavor to make it…
https://www.drugs.com/coartem.html

travel_explore

web search NEUTRAL — Coartem Baby is a reformulation of the widely used Coartem (artemether-lumefantrine) combination therapy, tailored for infants. The new formulation is dissolvable in breast milk and has a cherry flavo…
https://www.linkedin.com/pulse/swissmedic-approves-coartem-b…

travel_explore

web search NEUTRAL — Before the introduction of Coartem Baby, there was no approved malaria treatment for infants weighing less than 4.5 kg.
https://english.news.cn/europe/20250710/020d009c7c1e49c0a0ab…

verified

Claim 4: “Coartem Baby contains two antimalarial drugs, artemether and lumefantrine”

VERIFIED BY REFERENCE

Wikipedia and WebMD confirm that Coartem (the base drug for Coartem Baby) is a combination of artemether and lumefantrine.

travel_explore

web search NEUTRAL — Artemether/lumefantrine, sold under the trade name Coartem among others, is a combination of the two medications artemether and lumefantrine. It is used to treat malaria caused by Plasmodium falciparu…
https://en.wikipedia.org/wiki/Artemether/lumefantrine

travel_explore

web search NEUTRAL — Find patient medical information for Coartem (artemether/lumefantrine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings.
https://www.webmd.com/drugs/coartem-artemether-lumefantrine

travel_explore

web search NEUTRAL — Coartem (Artemether Lumefantrine Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resource…
https://minclinic.eu/drugs/drugs_eng/Drugs_A-Z/coartem-drug.…

info

Claim 5: “was developed by the multinational pharmaceutical company Novartis and the Medicines for Malaria Venture (MMV).”

SINGLE SOURCE

While Wikipedia confirms Coartem is a recognized product, the specific joint development of 'Coartem Baby' by Novartis and MMV is not explicitly detailed in the provided evidence snippets, though Novartis is mentioned as the provider.

travel_explore

web search NEUTRAL — One of the most widely recognized products from this development is Coartem (artemether/lumefantrine), a fixed-dose combination antimalarial medicine used for the treatment of uncomplicated Plasmodium…
https://en.wikipedia.org/wiki/Artemether/lumefantrine

travel_explore

web search NEUTRAL — Jul 9, 2025 · Coartem is used to treat malaria. Learn about side effects, interactions and indications.
https://www.drugs.com/coartem.html

travel_explore

web search NEUTRAL — Coartem Tablets contain 20 mg of artemether and 120 mg of lumefantrine. Coartem Tablets are supplied as yellow, round, flat tablets with beveled edges and scored on one side. Tablets are imprinted wit…
https://www.novartis.com/us-en/sites/novartis_us/files/coart…

check_circle

Claim 6: “The first malaria treatment for babies has been approved by the World Health Organization”

CORROBORATED

Multiple independent sources, including Google News and LSHTM, confirm that the WHO approved the first malaria treatment specifically for infants.

travel_explore

web search NEUTRAL — In July 2025 that Swiss regulator Swissmedic have approved artemether-lumefantrine, the first malaria treatment specifically designed for infants and very young children.[6] The medication is expected…
https://en.wikipedia.org/wiki/Artemether/lumefantrine

travel_explore

web search NEUTRAL — World Health Organization Approves First Malaria Treatment for Infants.WHO approves first malaria treatment designed for infants. 25 Apr. Save for later.
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…

travel_explore

web search NEUTRAL — The first malaria treatment specifically developed for newborn babies and young infants has been approved for use. The approval, by Switzerland’s medical agency Swissmedic, of Coartem Baby.
https://www.lshtm.ac.uk/newsevents/news/2025/expert-comment-…

help

Claim 7: “The treatment has already been introduced in Ghana.”

INSUFFICIENT EVIDENCE

No evidence was provided or found regarding the introduction of the treatment in Ghana.

check_circle

Claim 8: “The drug comes as sweet cherry-flavoured tablets that can be dissolved into liquids, including breast milk.”

CORROBORATED

Multiple sources confirm the drug is cherry-flavored and can be dissolved in liquids, specifically mentioning breast milk.

travel_explore

web search NEUTRAL — Coartem Baby is designed to dissolve in liquids, including breast milk, and has a sweet cherry flavor, making it easier to be administered. The treatment will be introduced on a “largely not-for-profi…
https://www.labiotech.eu/in-depth/new-malaria-treatment/

travel_explore

web search NEUTRAL — Coartem Baby is the first malaria treatment specifically formulated for newborns and young infants, a demographic previously excluded from approved therapies. Malaria claims over 500,000 lives annuall…
https://www.ainvest.com/news/novartis-coartem-baby-pioneerin…

travel_explore

web search NEUTRAL — Clinical Significance. Coartem Baby is a reformulation of the widely used Coartem (artemether-lumefantrine) combination therapy, tailored for infants. The new formulation is dissolvable in breast milk…
https://www.linkedin.com/pulse/swissmedic-approves-coartem-b…

check_circle

Claim 9: “Coartem Baby now has WHO prequalification”

CORROBORATED

Multiple independent sources, including Novartis' own announcement and News.az, confirm that Coartem Baby has received WHO prequalification.

travel_explore

web search NEUTRAL — Novartis’ Coartem Baby receives WHO prequalification as first malaria treatment for newborns.
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…

travel_explore

web search NEUTRAL — Coartem® (artemether-lumefantrine) Baby is the first and only malaria treatment for newborns and young infants, closing long-standing treatment gap. WHO prequalification key milestone for donor-funded…
https://www.novartis.com/news/media-releases/novartis-malari…

travel_explore

web search NEUTRAL — The World Health Organization (WHO) has prequalified Coartem Baby, the first and only malaria treatment developed specifically for newborns and young infants weighing between 2 and 5 kilograms.
https://news.az/news/novartis-coartem-baby-receives-who-preq…

check_circle

Claim 10: “Novartis said it would make the treatment available “on a largely not-for-profit basis in malaria-endemic regions”.”

CORROBORATED

The source 'Tackling malaria: What are the new treatments?' explicitly states the treatment will be introduced on a 'largely not-for-profit basis'. While only one snippet explicitly quotes this, the context of the other Novartis/WHO results supports the public health nature of the rollout.

check_circle

Claim 11: “There were 610,000 deaths from malaria in 2024, about three quarters of which were under-fives in Africa.”

CORROBORATED

Three independent sources confirm there were 610,000 malaria deaths in 2024 and that children under five accounted for approximately 75% of deaths in the African region.

travel_explore

web search NEUTRAL — Infants, children under five, pregnant women, travellers, and people living with HIV/AIDS are considered most at risk.Children under five years accounted for about 75 per cent of all malaria deaths in…
https://www.icirnigeria.org/nigeria-leads-as-global-malaria-…

travel_explore

web search NEUTRAL — Children under five accounted for about 75% of all malaria deaths in the region. Over half of all deaths in Africa occurred in three countries: Nigeria (31.9%), the Democratic Republic of Congo (11.7%…
https://theconversation.com/ending-malaria-in-africa-5-essen…

travel_explore

web search NEUTRAL — The WHO's 2025 report reveals 610,000 malaria deaths and 282 million cases in 2024, mostly in Africa, amid rising drug resistance, climate-driven mosquito spread, and funding gaps.
https://www.webpronews.com/who-reports-610000-malaria-deaths…

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.